Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 22 min ago
Peer-reviewedCC BY-NC 3.0Clinical and Molecular Hepatology

Risk assessment of cardiovascular disease-related mortality in metabolic dysfunction-associated steatotic liver disease

6 affiliations
  1. 1Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA
  2. 2Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA
  3. 3Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Morningside and West, New York, NY, USA
  4. 4Department of Medicine, Bridgeport Hospital, Yale New Haven Health, Bridgeport, CT, USA
  5. 5Department of Medicine, Division of Gastroenterology and Hepatology, University of Arizona College of Medicine, Phoenix, AZ, USA
  6. 6Department of Internal Medicine, Division of Gastroenterology and Hepatology, Banner University Medical Center, Phoenix, AZ, USA

Related

  1. Metabolic Dysfunction-Associated Fatty Liver Disease-Cardiovascular-Kidney-Metabolic (MAFLD-CKM): A Modified Framework to Predict Long-Term Mortality.
    Alaa M Mostafa, Yasser Fouad, Eman Abdelsameea +4
    Medical science monitor : international medical journal of experimental and clinical researchPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMC
  2. Metabolic and Renal Dysfunction Are Associated With Intraplaque Lipid Burden Assessed by Near‐Infrared Spectroscopy Intravascular Ultrasound: Insights Into the Cardiovascular–Kidney–Metabolic Axis
    Hyungdon Kook, Woohyeun Kim, Seong Rae Cho +1
    Journal of the American Heart AssociationPeer-reviewedLicence not statedCardiovascular medicineCrossref
  3. MASLD VCTE-C cohort: a prospective multicenter study linking liver fibrosis to cardiovascular outcomes in patients with metabolic dysfunction–associated steatotic liver disease
    Young Chang, Young Kul Jung, Han Ah Lee +8
    Frontiers in EndocrinologyPeer-reviewedCC BY 4.0Full textEndocrinology & metabolismCrossrefDOAJ
  4. Feasibility of multidomain cardiovascular-kidney-metabolic biomarker assessment for in-hospital mortality in older heart failure inpatients: an exploratory retrospective cohort study.
    Musa Bin Bashir, Chen Chen, Ho Yong Il +3
    BMC geriatricsPeer-reviewedCC BY-NC-NDFull textCardiovascular medicineEurope PMC
  5. Association between grip strength and cause-specific mortality in metabolic dysfunction-associated steatotic liver disease
    Chao Li, Zhijia Zhao, Ying Che +2
    Annals of HepatologyPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthDOAJ
BibTeX
@article{kim2026risk,
  title = {{Risk assessment of cardiovascular disease-related mortality in metabolic dysfunction-associated steatotic liver disease}},
  author = {Donghee Kim and Pojsakorn Danpanichkul and Do Han Kim and Donghyun Ko and Karn Wijarnpreecha and Aijaz Ahmed},
  journal = {Clinical and Molecular Hepatology},
  year = {2026},
  month = jun,
  doi = {10.3350/cmh.2026.0496},
  url = {https://doi.org/10.3350/cmh.2026.0496},
  note = {CC BY-NC 3.0},
}
RIS
TY  - JOUR
TI  - Risk assessment of cardiovascular disease-related mortality in metabolic dysfunction-associated steatotic liver disease
AU  - Donghee Kim
AU  - Pojsakorn Danpanichkul
AU  - Do Han Kim
AU  - Donghyun Ko
AU  - Karn Wijarnpreecha
AU  - Aijaz Ahmed
PY  - 2026
DA  - 2026/06/05
JO  - Clinical and Molecular Hepatology
DO  - 10.3350/cmh.2026.0496
UR  - https://doi.org/10.3350/cmh.2026.0496
SN  - 2287-2728
SN  - 2287-285X
ER  -